Covaxin
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt
Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday. “Covaxin has been approved by the Drugs Controller General of India (DCGI), for […]
4 years ago#Northeast Live Digital Desk
Centre to augment manufacturing capacity of COVAXIN under Mission Covid Suraksha
Amid the reports of shortage of Bharat Biotech’s COVID-19 vaccine, the Centre on Wednesday said it will double the current production capacity of COVAXIN by May-June and then increase it to nearly six to seven folds by July-August. The government of India said the COVAXIN production is expected to reach nearly 10 crore doses per […]
4 years ago#Northeast Live Digital Desk
Covaxin found to neutralise Indian variant of COVID-19, says Dr Anthony Fauci
White House Chief Medical Adviser and America’s top pandemic expert Dr Anthony Fauci has said that India’s home-grown coronavirus vaccine, Covaxin was effective against the Indian variant of the deadly virus. “This is something where we’re still gaining data on a daily basis. But the most recent data, was looking at convalescent Sera of COVID-19 […]
4 years ago#Northeast Live Digital Desk
COVAXIN neutralises multiple variants of SARS-COV-2, double mutant strain: ICMR
Indigenously-developed Covid-19 vaccine Covaxin, made by Bharat Biotech, neutralises multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday. The ICMR also informed that the Indian vaccine effectively neutralises the double mutant strain as well, which is being reported in many parts […]
4 years ago#Northeast Live Digital Desk
Covaxin production capacity to be doubled by May-June: Centre
The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021, the government announced on Friday as the country is witnessing a record surge in COVID-19 infections in past some weeks. In an effort to accelerate the development and production of indigenous […]
4 years ago#Northeast Live Digital Desk
PM Modi gets second dose of COVID-19 vaccine at AIIMS
Prime Minister Narendra Modi on Thursday took the second dose of the COVID-19 vaccine at the All India Institute of Medical Sciences (AIIMS) in New Delhi, 37 days after his first shot. Sharing the news on Twitter the Prime Minister said a Covid shot was among the few ways to defeat the virus. He urged […]
4 years ago#Northeast Live Digital Desk
PM Modi addresses vaccine hesitancy, gets Bharat Biotech’s Covaxin jab
Prime Minister Narendra Modi on Monday took the first dose of Covaxin, India’s homegrown coronavirus vaccine developed by biotechnology firm Bharat Biotech and Indian Council of Medical Research, addressing the hesitancy over the COVID-19 vaccine. PM Modi took the first dose of the vaccine at All India Institute of Medical Sciences (AIIMS) Delhi. “Took my […]
4 years ago#Northeast Live Digital Desk
Second COVID-19 vaccine shot to be administered from February 13
The central government on Thursday announced that the second dose of COVID-19 vaccine will be administered to health workers from February 13. 97 percent people who have received the first dose of Coronavirus vaccine are satisfied, said the central government. The Union Health Ministry reviewed the Covid situation in the country and said that 47 […]
4 years ago#Northeast Live Digital Desk
Covaxin effective on UK virus strain of COVID-19: ICMR
An Indian Council of Medical Research (ICMR) study on Covaxin shows a comparable neutralization activity of the vaccinated individuals against UK-variant strain. The ICMR’s National Institute of Virology scientist performed the plaque reduction neutralization test using sera collected from the 26 recipients of Bharat Biotech’s coronavirus vaccine (COVAXIN) against UK-variant strain. “A comparable neutralization activity […]
4 years ago#Northeast Live Digital Desk
AIIMS Director reassures people COVAXIN vaccine is safe
Urging the people to have faith in India’s researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr. Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech’s COVAXIN vaccine is safe. “I want to reassure everyone that the vaccine (COVAXIN) is safe. It is efficacious. We have to vaccinate a […]
4 years ago